Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies

被引：0
|
作者：
Li Xuan
Fen Huang
Zhiping Fan
Hongsheng Zhou
Xian Zhang
Guopan Yu
Yu Zhang
Can Liu
Jing Sun
Qifa Liu
机构：
[1] Nanfang Hospital,Department of Hematology
[2] Southern Medical University,undefined
来源：
Journal of Hematology & Oncology | / 5卷
关键词：
Epstein-Barr virus; Cytomegalovirus; Conditioning; Hematological malignancies; Allogeneic hematopoietic stem cell transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cytokine Gene Polymorphisms and Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Lin, Ren
    Fan, Zhiping
    Zhao, Ke
    Jiang, Qianli
    Sun, Jing
    Liu, Qifa
    BLOOD, 2015, 126 (23)
  • [22] Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation
    Xiu-li Wu
    Qi-fa Liu
    Journal of Hematology & Oncology, 5 (Suppl 1)
  • [23] Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders
    Islam, Md Serajul
    Anoop, Parameswaran
    Gordon-Smith, Edward C.
    Rice, Phil
    Datta-Nemdharry, Preeti
    Marsh, Judith C. W.
    HEMATOLOGY, 2010, 15 (05) : 344 - 350
  • [24] Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
    Carpenter, Ben
    Haque, Tanzina
    Dimopoulou, Maria
    Atkinson, Claire
    Roughton, Michael
    Grace, Sarah
    Denovan, Shari
    Fielding, Adele
    Kottaridis, Panagiotis D.
    Griffiths, Paul
    Mackinnon, Stephen
    Emery, Vincent
    Chakraverty, Ronjon
    TRANSPLANTATION, 2010, 90 (05) : 564 - 570
  • [25] Malignancies after heart transplantation:: presence of Epstein-Barr virus and cytomegalovirus
    Mattila, PS
    Aalto, SM
    Heikkilä, L
    Mattila, S
    Nieminen, M
    Auvinen, E
    Hedman, K
    Tarkkanen, J
    CLINICAL TRANSPLANTATION, 2001, 15 (05) : 337 - 342
  • [26] Adoptive T-cell Transfer for Refractory Viral Infections with Cytomegalovirus, Epstein-Barr Virus or Adenovirus after Allogeneic Stem Cell Transplantation
    Feucht, J.
    Joachim, L.
    Lang, P.
    Feuchtinger, T.
    KLINISCHE PADIATRIE, 2013, 225 (03): : 164 - 169
  • [27] Management of Epstein-Barr virus reactivation following allogeneic stem cell transplantation
    Lankester, Arjan C.
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (03) : 163 - 165
  • [28] Active cytomegalovirus infection is not a risk factor for Epstein-Barr virus DNAemia in the allogeneic stem cell transplantation setting
    Gimenez, Estela
    Solano, Carlos
    Bravo, Dayana
    Amat, Paula
    Jose Remigia, Maria
    Alberola, Juan
    Navarro, David
    CLINICAL TRANSPLANTATION, 2014, 28 (04) : 508 - 509
  • [29] A Co-Reactivation Model of Cytomegalovirus and Epstein-Barr Virus after Allogeneic Hematopoietic Stem Cell Transplantation Was Constructed to Predict Mortality after Transplantation
    Ren, Jinhua
    Chen, Shaozhen
    Hu, Jianda
    Yang, Ting
    BLOOD, 2023, 142
  • [30] Features of Epstein-Barr virus reactivation after reduced-intensity conditioning allogeneic stem cell transplantation
    Peric, Z.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Milpied, N.
    Vrhovac, R.
    Harousseau, J. L.
    Moreau, P.
    Coste-Burel, M.
    Imbert-Marcille, B. M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S287 - S287
12345